We are monitoring the impact of COVID-19 on North America Hemostats Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4990
Share on
Share on

North America Hemostats Market Research Report - Segmented By Product Type, Application, Distribution Channel and Country (The U.S., Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4990
Pages: 145

North America Hemostats Market Size (2021 to 2026)

The size of the North American Hemostats market has been predicted at USD 1.59 billion in 2021. It is expected to grow at a CAGR of 5.9% and be worth USD 7.14 billion by 2026. It captures 35% of the global market share.

The increasing number of surgical procedures performed, the increased focus on R&D, the rising prevalence of sports-related injuries and spinal disorders, and the expanding emphasis on effective blood loss control in patients during surgeries are expected to promote the growth rate of the North American hemostats market. The hemostats market is at an all-time high, caused by an increase in patients suffering from chronic ailments. In addition, the rise in unhealthy lifestyles, combined with technical improvements in the healthcare industry, is expected to drive up demand for hemostats, boosting the market significantly.

Furthermore, the government's reimbursement rules have had a positive impact on the industry. Tissue sealants, tissue adhesives, and adhesion avoidance solutions replace traditional sutures for wound and incision closure. The rising medical tourism sector, increasing purchasing power, rapidly expanding healthcare infrastructure, and increased public awareness of healthcare practices are expected to favor the North American hemostats market’s growth during the forecast period. In addition, increasing market research and development activities, an increase in the number of hospitals and surgical centers, and an increase in emerging markets are expected to provide new growth possibilities for the market.

In addition, nano- and micro-materials are being used to treat uncontrolled hemorrhage and internal bleeding. Advanced laparoscopic hemostats have also been introduced to the market, aiming to improve the quality of surgical operations while also allowing for less invasive treatments. Hemostats have several advantages, including shorter surgical times, less infection risk, and a lower risk of consequences from excessive bleeding. Hemostats aid in the establishment of hemostasis in pre-hospital situations and the prevention of hemorrhage-related fatalities.

The use of hemostats is predicted to be hampered by the adverse effects and allergic reactions they cause. The high cost of hemostats, government laws and regulations, and the need for skilled specialists are expected to restrict the North American hemostats market growth. In addition, Hemostats must be handled by trained personnel since poor artery closure during surgical procedures might result in continued bleeding or ischemia. In addition, product recalls are on the rise. The market is highly consolidated, among other things, which is estimated to hamper the market’s growth rate and make the hemostats market even more challenging to grow.

This research report on the North American hemostats market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Topical Hemostats
  • Tissue Sealants
  • Cyanoacrylate-based Tissue Adhesives
  • Adhesion Prevention Products

By Application: 

  • Wound Closure
  • Surgical Hemostats

By Distribution Channel: 

  • Direct Tenders
  • Retail

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American hemostats market accounted for the largest share in 2020 in the global and is expected to remain at the top till the end of 2026. Highly advanced healthcare systems in this region, coupled with their ready adoption, are the factors attributable to the observable trend mentioned above. The growing elderly population, the increasing number of procedures conducted in the region, and the strong presence of significant market participants in this region contribute to North America's substantial share. The economies of the United States and Canada are included mainly by the North American regional market. Because of their cost-effectiveness, the number of outpatient procedures conducted in hospital settings has increased. As a result, hemostats have become more popular as an alternative to standard wound closure methods in various situations, including endoscopic treatments. The market for hemostats in the United States is the fastest-growing in the area, with the largest market share. This can be linked to the increased need to prevent patients from bleeding after surgery.

KEY MARKET PLAYERS:

A few notable companies playing a dominant role in the North American hemostats market profiled in this report are 3M, ADCO North America, Inc., Abbott Laboratories. Other players in the market include Advanced Medical Solutions Group, Plc. and Dymax Corporation.

1.Introduction         

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods  

               1.4 General Study Assumptions                 

2. Research Methodology                  

               2.1 Introduction     

               2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

               2.3 Analysis Design

               2.4 Study Timeline 

3. Overview             

               3.1 Executive Summary                

               3.2 Key Inferences 

               3.3 Epidemology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

               4.1 Market Drivers 

               4.2 Market Restraints                   

               4.3 Key Challenges 

               4.4 Current Opportunities in the Market               

5. Market Segmentation                    

               5.1 Product Type    

      5.1.1 Introduction           

      5.1.2 Topical hemostats

                     5.1.2.1 Collagen-based topical hemostats

                     5.1.2.2 Oxidized regenerated cellulose-based topical hemostat

                     5.1.2.3 Gelatin-based topical hemostat

                     5.1.2.4 Thrombin-based topical hemostat

                     5.1.2.5 Combination topical hemostat

      5.1.3 Tissue Sealants      

                     5.1.3.1 Fibrin sealants

                     5.1.3.2 Protein-based sealants

      5.1.4 Cyanoacrylate-based tissue adhesives         

      5.1.5 Adhesion prevention products        

      5.1.6 Y-o-Y Growth Analysis, By Product Type     

      5.1.7 Market Attractiveness Analysis, By Product Type    

      5.1.8 Market Share Analysis, By Product Type     

               5.2 Application                 

      5.2.1 Wound Closure     

      5.2.2 Surgical Hemostats             

      5.2.3 Y-o-Y Growth Analysis, By Application         

      5.2.4 Market Attractiveness Analysis, By Application       

      5.2.5 Market Share Analysis, By Application        

               5.3 Distribution Channel     

      5.3.1 Direct Tenders       

      5.3.2 Retail        

      5.3.3 Y-o-Y Growth Analysis, By Distribution Channel       

      5.3.4 Market Attractiveness Analysis, By Distribution Channel     

      5.3.5 Market Share Analysis, By Distribution Channel      

               5.4 End User                     

      5.4.1 Hospitals  

      5.4.2 Ambulatory Centers            

      5.4.3 Community Healthcare      

      5.4.4 Clinics       

      5.4.5 Y-o-Y Growth Analysis, By End User             

      5.4.6 Market Attractiveness Analysis, By End User            

      5.4.7 Market Share Analysis, By End User             

6. Geographical Analysis                    

               6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                     6.1.3.1 By Geographical Area

                     6.1.3.2 By Product Type

      6.1.4  Market Attractiveness Analysis      

                     6.1.4.1 By Geographical Area

                     6.1.4.2 By Product Type

      6.1.5  Market Share Analysis       

                     6.1.5.1 By Geographical Area

                     6.1.5.2 By Product Type

               6.2 United States   

               6.3 Canada                       

7. Strategic Analysis              

               7.1 PESTLE analysis

      7.1.1 Political    

      7.1.2 Economic 

      7.1.3 Social        

      7.1.4 Technological        

      7.1.5 Legal         

      7.1.6 Environmental       

               7.2 Porter’s Five analysis     

      7.2.1 Bargaining Power of Suppliers         

      7.2.2 Bargaining Power of Consumers     

      7.2.3 Threat of New Entrants      

      7.2.4 Threat of Substitute Products and Services

      7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis               

               8.1 Johnson & Johnson Services, Inc.                     

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments        

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

               8.2 C. R. Bard, Inc. 

               8.3 Baxter 

               8.4 B. Braun Melsungen Ag                        

               8.5 Pfizer Inc.                   

               8.6 Vascular Solutions, Inc.                        

               8.7 Gelita Medical Gmbh    

               8.8 Equimedical               

               8.9 Integra Lifesciences Holdings Corporation                    

               8.10 Z-Medica, LLC                        

9. Competitive Landscape                 

               9.1 Market share analysis   

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures  

               9.4 New Product Launches 

10. Market Outlook and Investment Opportunities                 

Appendix                  

               a) List of Tables                

               b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Hemostats Market, By Product Type, From 2021 to 2026 (USD Billion)
  2. North America Topical hemostats Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Tissue Sealants Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Cyanoacrylate-based tissue adhesives Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Adhesion prevention products Market, By Region, From 2021 to 2026 (USD Billion)
  6. United States Hemostats Market, By Product Type, From 2021 to 2026 (USD Billion)
  7. Canada Hemostats Market, By Product Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample